Evaluating the safety, effectiveness and acceptability of treatment of incomplete second-trimester abortion using misoprostol provided by midwives compared with physicians: study protocol for a randomized controlled equivalence trial

Susan Atuhairwe, Josaphat Byamugisha, Marie Klingberg-Allvin, Amanda Cleeve, Claudia Hanson, Nazarius Mbona Tumwesigye, Othman Kakaire, Kristina Gemzell Danielsson, Susan Atuhairwe, Josaphat Byamugisha, Marie Klingberg-Allvin, Amanda Cleeve, Claudia Hanson, Nazarius Mbona Tumwesigye, Othman Kakaire, Kristina Gemzell Danielsson

Abstract

Background: A large proportion of abortion-related mortality and morbidity occurs in the second trimester of pregnancy. The Uganda Ministry of Health policy restricts management of second-trimester incomplete abortion to physicians who are few and unequally distributed, with most practicing in urban regions. Unsafe and outdated methods like sharp curettage are frequently used. Medical management of second-trimester post-abortion care by midwives offers an advantage given the difficulty in providing surgical management in low-income settings and current health worker shortages. The study aims to assess the safety, effectiveness and acceptability of treatment of incomplete second-trimester abortion using misoprostol provided by midwives compared with physicians.

Methods: A randomized controlled equivalence trial implemented at eight hospitals and health centers in Central Uganda will include 1192 eligible women with incomplete abortion of uterine size > 12 weeks up to 18 weeks. Each participant will be randomly assigned to undergo a clinical assessment and treatment by either a midwife (intervention arm) or a physician (control arm). Enrolled participants will receive 400 μg misoprostol administered sublingually every 3 h up to five doses within 24 h at the health facility until a complete abortion is confirmed. Women who do not achieve complete abortion within 24 h will undergo surgical uterine evacuation. Pre discharge, participants will receive contraceptive counseling and information on what to expect in terms of side effects and signs of complications, with follow-up 14 days later to assess secondary outcomes. Analyses will be by intention to treat. Background characteristics and outcomes will be presented using descriptive statistics. Differences between groups will be analyzed using risk difference (95% confidence interval) and equivalence established if this lies between the predefined range of - 5% and + 5%. Chi-square tests will be used for comparison of outcome and t tests used to compare mean values. P ≤ 0.05 will be considered statistically significant.

Discussion: Our study will provide evidence to inform national and international policies, standard care guidelines and training program curricula on treatment of second-trimester incomplete abortion for improved access.

Trial registration: ClinicalTrials.gov, NCT03622073 . Registered on 9 August 2018.

Keywords: Contraception; Incomplete abortion; Misoprostol; Post abortion care; Second trimester; Task sharing; Uganda.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Trial design. ITT intention to treat
Fig. 2
Fig. 2
Standard Protocol Items: Recommendations for Interventional Trials figure—participant enrolment and follow-up. PAC post-abortion care

References

    1. World Health Organization, World Bank, United Nations Population Fund & United Nations Children’s Fund ( UNICEF). Trends in maternal mortality: 1990-2015: estimates from WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. World Health Organization. 2015. .
    1. Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333. doi: 10.1016/S2214-109X(14)70227-X.
    1. Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, et al. Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet. 2016;388(10041):258–267. doi: 10.1016/S0140-6736(16)30380-4.
    1. Ganatra B, Gerdts C, Rossier C, Johnson BR, Jr, Tuncalp O, Assifi A, et al. Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model. Lancet. 2017;390(10110):2372–2381. doi: 10.1016/S0140-6736(17)31794-4.
    1. Faundes A. Strategies for the prevention of unsafe abortion. Int J Gynaecol Obstet. 2012;119(Suppl 1):S68–S71. doi: 10.1016/j.ijgo.2012.03.021.
    1. In: nd, editor. Safe Abortion: Technical and Policy Guidance for Health Systems. WHO Guidelines Approved by the Guidelines Review Committee. Geneva. 2012.
    1. Consortium PCP. PAC model 2015 [cited 22 Sep 2016]. Available from: .
    1. Klingberg-Allvin M, Cleeve A, Atuhairwe S, Tumwesigye NM, Faxelid E, Byamugisha J, et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet. 2015;385(9985):2392–2398. doi: 10.1016/S0140-6736(14)61935-8.
    1. Makenzius M, Oguttu M, Klingberg-Allvin M, Gemzell-Danielsson K, Odero TMA, Faxelid E. Post-abortion care with misoprostol—equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya. BMJ Open. 2017;7(10):e016157. doi: 10.1136/bmjopen-2017-016157.
    1. Uganda Bureau of Statistcs (UBOS) and ICF . Uganda Demographic and Health Survey 2016: Key Indicators Report. Kampala, Uganda: UBOS, and Rockville, MD: UBOS and ICF; 2017.
    1. Mbonye AK, Asimwe JB, Kabarangira J, Nanda G, Orinda V. Emergency obstetric care as the priority intervention to reduce maternal mortality in Uganda. Int J Gynaecol Obstetrics. 2007;96(3):220–225. doi: 10.1016/j.ijgo.2006.12.017.
    1. Nalwadda G, Mirembe F, Byamugisha J, Faxelid E. Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives. BMC public health. 2010;10:530.
    1. Nalwadda G, Mirembe F, Tumwesigye NM, Byamugisha J, Faxelid E. Constraints and prospects for contraceptive service provision to young people in Uganda: providers’ perspectives. BMC Health Serv Res. 2011;11:220.
    1. United Nations, Department of Economic and Social Affairs, Population Division . World population policies 2009. New York: United Nations; 2010.
    1. Singh S, Prada E, Mirembe F, Kiggundu C. The incidence of induced abortion in Uganda. Int Fam Plan Perspect. 2005;31(4):183–191. doi: 10.1363/3118305.
    1. Uganda Ministry of Health . Health sector strategic plan III: 2010/11–2014/15. Kampala: Ministry of Health; 2010.
    1. Cleeve A, Faxelid E, Nalwadda G, Klingberg-Allvin M. Abortion as agentive action: reproductive agency among young women seeking post-abortion care in Uganda. Cult Health Sex. 2017;19(11):1286–1300. doi: 10.1080/13691058.2017.1310297.
    1. Larsson S, Eliasson M, Klingberg Allvin M, Faxelid E, Atuyambe L, Fritzell S. The discourses on induced abortion in Ugandan daily newspapers: a discourse analysis. Reprod Health. 2015;12:58. doi: 10.1186/s12978-015-0049-0.
    1. Ministry of Health, Uganda. National Policy Guidelines for Sexual Reproductive Health Services. In: Reproductive Health Division CHD, editor. 4th ed. Kampala: Reproductive Health Division, Community Health Department; 2011
    1. Uganda Bureau of Statistics (UBOS) and ICF International Inc . Uganda Demographic and Health Survey 2011. Kampala: UBOS and Calverton, MD: ICF International Inc. Uganda; 2012.
    1. Paul M, Gemzell-Danielsson K, Kiggundu C, Namugenyi R, Klingberg-Allvin M. Barriers and facilitators in the provision of post-abortion care at district level in central Uganda—a qualitative study focusing on task sharing between physicians and midwives. BMC Health Serv Res. 2014;14(1):28. doi: 10.1186/1472-6963-14-28.
    1. Mark AG, Edelman A, Borgatta L. Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion. Int J Gynaecol Obstetrics. 2015;129(2):98–103. doi: 10.1016/j.ijgo.2014.11.011.
    1. Cleeve A, Byamugisha J, Gemzell-Danielsson K, Mbona Tumwesigye N, Atuhairwe S, Faxelid E, et al. Women's acceptability of misoprostol treatment for incomplete abortion by midwives and physicians—secondary outcome analysis from a randomized controlled equivalence trial at district level in Uganda. PLoS One. 2016;11(2):e0149172. doi: 10.1371/journal.pone.0149172.
    1. Osur Joachim, Baird Traci L., Levandowski Brooke A., Jackson Emily, Murokora Daniel. Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation. Global Health Action. 2013;6(1):19649. doi: 10.3402/gha.v6i0.19649.
    1. Nabudere Harriet, Asiimwe Delius, Mijumbi Rhona. Task shifting in maternal and child health care: An evidence brief for Uganda. International Journal of Technology Assessment in Health Care. 2011;27(2):173–179. doi: 10.1017/S0266462311000055.
    1. Dawson A. J., Buchan J., Duffield C., Homer C. S. E., Wijewardena K. Task shifting and sharing in maternal and reproductive health in low-income countries: a narrative synthesis of current evidence. Health Policy and Planning. 2013;29(3):396–408. doi: 10.1093/heapol/czt026.
    1. Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol. 2007;46(5):947–954. doi: 10.1016/j.jhep.2007.02.015.
    1. General Assembly of the World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14–18.
    1. Prada E, Atuyambe LM, Blades NM, Bukenya JN, Orach CG, Bankole A. Incidence of induced abortion in Uganda, 2013: new estimates since 2003. PLoS One. 2016;11(11):e0165812. doi: 10.1371/journal.pone.0165812.
    1. Ministry of Health, Uganda. Uganda Clinical Guidelines, National Guidelines for Management of Common Conditions. Ministry of Health. Kampala 2012.
    1. Reeves MF, Fox MC, Lohr PA, Creinin MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol. 2009;34(1):104–109. doi: 10.1002/uog.6404.
    1. PASS software version 14 for equivalence studies sample size computations Statistical, graphics, and sample size software 2016 [cited 10 Aug 2016]. Available from: .
    1. Pongsatha S, Tongsong T. Randomized controlled trial comparing efficacy between a vaginal misoprostol loading and non-loading dose regimen for second-trimester pregnancy termination. J Obstet Gynaecol Res. 2014;40(1):155–160. doi: 10.1111/jog.12147.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit